Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Different effects of biological drugs in rheumatoid arthritis.

Atzeni F, Benucci M, Sallì S, Bongiovanni S, Boccassini L, Sarzi-Puttini P.

Autoimmun Rev. 2013 Mar;12(5):575-9. doi: 10.1016/j.autrev.2012.10.020. Review.

PMID:
23219774
2.

Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis.

Barrera P, van der Maas A, van Ede AE, Kiemeney BA, Laan RF, van de Putte LB, van Riel PL.

Rheumatology (Oxford). 2002 Apr;41(4):430-9.

3.

Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.

[No authors listed]

Prescrire Int. 2010 Feb;19(105):30-4. Review.

PMID:
20455343
5.

Drugs that block tumour necrosis factor: experience in patients with rheumatoid arthritis.

Moreland LW.

Pharmacoeconomics. 2004;22(2 Suppl 1):39-53. Review. Erratum in: Pharmacoeconomics. 2004;22(8):547.

PMID:
15157003
6.

Twelve years' experience with etanercept in the treatment of rheumatoid arthritis: how it has changed clinical practice.

Atzeni F, Sarzi-Puttini P.

Expert Rev Clin Immunol. 2012 Mar;8(3):213-22. doi: 10.1586/eci.12.6.

PMID:
22390484
7.

A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis.

Ma MH, Kingsley GH, Scott DL.

Rheumatology (Oxford). 2010 Jan;49(1):91-8. doi: 10.1093/rheumatology/kep331. Review.

9.

Certolizumab pegol in the treatment of rheumatoid arthritis: a comprehensive review of its clinical efficacy and safety.

Mease PJ.

Rheumatology (Oxford). 2011 Feb;50(2):261-70. doi: 10.1093/rheumatology/keq285. Review.

10.

Biologics in rheumatoid arthritis.

Sharma PK, Hota D, Pandhi P.

J Assoc Physicians India. 2004 Mar;52:231-6. Review.

PMID:
15636315
11.

[A novel treatment option in rheumatoid arthritis: abatacept, a selective modulator of T-cell co-stimulation].

Dejaco C, Duftner C, Wipfler E, Schirmer M.

Wien Med Wochenschr. 2009;159(3-4):70-5. doi: 10.1007/s10354-008-0590-3. Review. German.

PMID:
19247593
12.

Cost utility of tumour necrosis factor-α inhibitors for rheumatoid arthritis: an application of Bayesian methods for evidence synthesis in a Markov model.

Nguyen CM, Bounthavong M, Mendes MA, Christopher ML, Tran JN, Kazerooni R, Morreale AP.

Pharmacoeconomics. 2012 Jul 1;30(7):575-93. doi: 10.2165/11594990-000000000-00000. Review. Erratum in: Pharmacoeconomics. 2012 Nov 1;30(11):1096.

PMID:
22640174
13.

Comparison of combination therapies in the treatment of rheumatoid arthritis: leflunomide-anti-TNF-alpha versus methotrexate-anti-TNF-alpha.

De Stefano R, Frati E, Nargi F, Baldi C, Menza L, Hammoud M, Galeazzi M.

Clin Rheumatol. 2010 May;29(5):517-24. doi: 10.1007/s10067-009-1349-y.

PMID:
20082236
14.

Use of biologics in rheumatoid arthritis: current and emerging paradigms of care.

Curtis JR, Singh JA.

Clin Ther. 2011 Jun;33(6):679-707. doi: 10.1016/j.clinthera.2011.05.044. Review.

15.

Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?

Schwartzman S, Fleischmann R, Morgan GJ Jr.

Arthritis Res Ther. 2004;6 Suppl 2:S3-S11. Review.

16.

Abatacept in biologic-naïve patients and TNF inadequate responders: clinical data in focus.

Sherrer Y.

Curr Med Res Opin. 2008 Aug;24(8):2283-94. doi: 10.1185/03007990802223129. Review.

PMID:
18590608
17.
18.

Influence of tumor necrosis factor α in rheumatoid arthritis.

Kulp W, Corzillus M, Greiner W, Pientka L, Siebert U, von der Schulenburg JM, Wasem J.

GMS Health Technol Assess. 2005 Dec 21;1:Doc12.

19.

[IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy].

Fiocco U, Vezzù M, Cozzi L, Todesco S.

Reumatismo. 2004 Jan-Mar;56(1 Suppl 1):62-73. Review. Italian.

20.

Innovative treatment approaches for rheumatoid arthritis. Combination therapy.

Borigini MJ, Paulus HE.

Baillieres Clin Rheumatol. 1995 Nov;9(4):689-710. Review.

PMID:
8591649
Items per page

Supplemental Content

Support Center